Legend Biotech Corporation (LEGN)

NASDAQ: LEGN · Real-Time Price · USD

33.47

-0.27 (-0.80%)

At close: Apr 16, 2025, 4:00 PM

32.87

-0.60 (-1.79%)

After-hours: Apr 16, 2025, 5:19 PM EDT

Legend Biotech Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Operating Revenue	620.98	284.96	116.68	65.4	75	Upgrade
Other Revenue	6.26	0.18	0.33	3.42	-	Upgrade
Revenue	627.24	285.14	117.01	68.83	75	Upgrade
Revenue Growth (YoY)	119.97%	143.70%	70.00%	-8.23%	21.36%	Upgrade
Cost of Revenue	648.13	526.43	401.01	313.35	232.16	Upgrade
Gross Profit	-20.88	-241.29	-284.01	-244.52	-157.16	Upgrade
Selling, General & Admin	284.26	200.93	174.05	149.5	72.71	Upgrade
Operating Expenses	284.26	200.93	174.05	149.5	72.71	Upgrade
Operating Income	-305.15	-442.22	-458.05	-394.02	-229.87	Upgrade
Interest Expense	-21.62	-21.79	-10.8	-0.9	-0.2	Upgrade
Interest & Investment Income	61.2	54.49	8.18	0.97	2.93	Upgrade
Currency Exchange Gain (Loss)	108.51	-28.65	-9.88	-	0.07	Upgrade
Other Non Operating Income (Expenses)	3.34	-82.61	24.22	-12.27	-1.23	Upgrade
EBT Excluding Unusual Items	-153.71	-520.78	-446.33	-406.22	-228.29	Upgrade
Gain (Loss) on Sale of Investments	-	0.66	0.6	-	0.05	Upgrade
Gain (Loss) on Sale of Assets	-	-	-	-0.97	-0.06	Upgrade
Asset Writedown	-4.42	-	-	-	-	Upgrade
Other Unusual Items	-	-	-	-	-79.98	Upgrade
Pretax Income	-158.13	-520.12	-445.72	-407.2	-308.29	Upgrade
Income Tax Expense	18.89	-1.86	0.63	-3.61	-41.91	Upgrade
Net Income	-177.03	-518.25	-446.35	-403.58	-266.37	Upgrade
Net Income to Common	-177.03	-518.25	-446.35	-403.58	-266.37	Upgrade
Shares Outstanding (Basic)	183	176	159	141	118	Upgrade
Shares Outstanding (Diluted)	183	176	159	141	118	Upgrade
Shares Change (YoY)	3.84%	10.71%	12.91%	19.21%	18.15%	Upgrade
EPS (Basic)	-0.97	-2.94	-2.81	-2.87	-2.25	Upgrade
EPS (Diluted)	-0.97	-2.94	-2.81	-2.87	-2.26	Upgrade
Free Cash Flow	-158.14	-413.36	-222.21	-240.66	-249.26	Upgrade
Free Cash Flow Per Share	-0.86	-2.35	-1.40	-1.71	-2.11	Upgrade
Gross Margin	-3.33%	-84.62%	-242.73%	-	-209.55%	Upgrade
Operating Margin	-48.65%	-155.09%	-391.48%	-572.49%	-306.49%	Upgrade
Profit Margin	-28.22%	-181.75%	-381.48%	-586.38%	-355.16%	Upgrade
Free Cash Flow Margin	-25.21%	-144.97%	-189.91%	-349.67%	-332.34%	Upgrade
EBITDA	-294.29	-431.48	-445.41	-385.88	-223.63	Upgrade
EBITDA Margin	-46.92%	-151.32%	-	-	-298.18%	Upgrade
D&A For EBITDA	10.86	10.73	12.65	8.14	6.23	Upgrade
EBIT	-305.15	-442.22	-458.05	-394.02	-229.87	Upgrade
EBIT Margin	-48.65%	-155.09%	-	-	-	Upgrade
Revenue as Reported	627.24	285.14	117.01	68.83	75	Upgrade

Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q